Huang Jingxian, Zhu Hongguo, Li Shanshan, Qiu Jing, Yang Hougang, Zheng Fengping, Luo Zhifeng, Yan Qiang, Liu Fanna, Yin Lianghong, Tang Donge, Dai Yong
Institute of Kidney Disease and Blood Purification, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China.
Comprehensive Health Industry Research Center, Taizhou Research Institute, Southern University of Science and Technology, Taizhou 317000, China.
ACS Omega. 2025 Apr 24;10(17):17208-17220. doi: 10.1021/acsomega.4c07827. eCollection 2025 May 6.
IgA nephropathy represents a significant challenge in nephrology research, and an understanding of its underlying molecular mechanisms is crucial. In this study, we conducted a comprehensive proteomic investigation of IgA nephropathy utilizing microdissection techniques combined with data-independent acquisition technology. Our analysis focused on differentially expressed proteins in the glomeruli, interstitium, and tubules of the kidney. Functional enrichment analysis revealed distinct pathway enrichment patterns, with fatty acid synthesis predominating in the glomerulus and complement and coagulation pathways predominantly enriched in the tubules. These pathway enrichments suggest potential key contributors to the pathogenesis of IgA nephropathy. Furthermore, our study identified ATP1B1 and COX4I1 in the glomerulus and SLC22A13 in the tubules as promising diagnostic markers for the disease. Meanwhile, C4A and APEX1 proteins were identified as valuable biomarkers for assessing disease progression. This research could provide valuable insights into the proteomic alterations associated with IgA nephropathy and offer potential targets for further therapeutic exploration.
IgA肾病是肾脏病学研究中的一项重大挑战,了解其潜在的分子机制至关重要。在本研究中,我们利用显微切割技术结合数据非依赖采集技术对IgA肾病进行了全面的蛋白质组学研究。我们的分析聚焦于肾脏肾小球、间质和肾小管中差异表达的蛋白质。功能富集分析揭示了不同的通路富集模式,脂肪酸合成在肾小球中占主导地位,而补体和凝血通路在肾小管中主要富集。这些通路富集提示了IgA肾病发病机制的潜在关键因素。此外,我们的研究确定肾小球中的ATP1B1和COX4I1以及肾小管中的SLC22A13为该疾病有前景的诊断标志物。同时,C4A和APEX1蛋白被确定为评估疾病进展的有价值生物标志物。这项研究可为与IgA肾病相关的蛋白质组学改变提供有价值的见解,并为进一步的治疗探索提供潜在靶点。